共 50 条
- [31] Randomized Phase 2 Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide, in Children and Adults with Refractory or Relapsed Rhabdomyosarcoma (RMS)PEDIATRIC BLOOD & CANCER, 2019, 66 : S5 - S6Defachelles, A. S.Bogart, E.Casanova, M.Merks, H.Bisogno, G.Calareso, G.Gallego, S.Gatz, S.Le Deley, M. C.Mc Hugh, K.Probst, A.Rocourt, N.Van Rijn, R.Wheatley, K.Minard-Colin, V.Chisholm, J.
- [32] IRINOTECAN AND TEMOZOLOMIDE ACTIVITY FOR RELAPSED/PROGRESSIVE NEUROBLASTOMA DURING NAXITAMAB IMMUNOTHERAPYPEDIATRIC BLOOD & CANCER, 2022, 69 : S223 - S224Perez, Juan Pablo MunozGorostegui, MaiteRodriguez, Amalia VaroHeredia, Alicia CastanedaGarraus, MoiraSanta-Maria, VicenteRafael, Margarida SimaoMora, Jaume
- [33] Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group StudyJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 208 - 213Bagatell, RochelleLondon, Wendy B.Wagner, Lars M.Voss, Stephan D.Stewart, Clinton F.Maris, John M.Kretschmar, CynthiaCohn, Susan L.
- [34] Phase I study of vincristine, irinotecan, and 131I-MIBG for patients with relapsed or refractory neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) study.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)DuBois, S. G.Chesler, L.Groshen, S. G.Hawkins, R.Goodarzian, F.Yanik, G. A.Stewart, C. F.Mosse, Y. P.Maris, J. M.Villablanca, J.Matthay, K. K.
- [35] A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid TumorsPLOS ONE, 2013, 8 (07):Venkatramani, RajkumarMalogolowkin, MarcioDavidson, Tom B.May, WilliamSposto, RichardMascarenhas, Leo
- [36] Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (10) : 1135 - 1145Moreno, LucasWeston, RebekahOwens, CormacValteau-Couanet, DominiqueGambart, MarionCastel, VictoriaZwaan, C. MichelNysom, KarstenGerber, NicolasCastellano, AuroraLaureys, GenevieveLadenstein, RuthRoessler, JochenMakin, GuyMurphy, DermotMorland, BruceVaidya, SuchetaThebaud, Estellevan Eijkelenburg, NatashaTweddle, Deborah A.Barone, GiuseppeTandonnet, JulieCorradini, NadegeChastagner, PascalPaillard, CatherineBautista, Francisco J.Gallego Melcon, SoledadDe Wilde, BramMarshall, LynleyGray, JulietBurchill, Susan A.Schleiermacher, GudrunChesler, LouisPeet, AndrewLeach, Martin O.Mchugh, KieranHayes, RoisinJerome, NeilCaron, HubertLaidler, JenniferFenwick, NicolaHolt, GraceMoroz, VeronicaKearns, PamelaGates, SimonPearson, Andrew D. J.Wheatley, Keith
- [37] Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) TrialJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (12) : 1368 - +DuBois, Steven G.Marachelian, ArazFox, ElizabethKudgus, Rachel A.Reid, Joel M.Groshen, SusanMalvar, JemilyBagatell, RochelleWagner, LarsMaris, John M.Hawkins, RandallCourtier, JesseLai, HollieGoodarzian, FaribaShimada, HiroyukiCzarnecki, ScarlettTsao-Wei, DeniceMatthay, Katherine K.Mosse, Yael P.
- [38] MOLECULAR RADIOTHERAPY WITH MATIN: IODINE-131 META-IODOBENZYLGUANIDINE AND TOPOTECAN IN NEUROBLASTOMA. TOXICITY AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY NEUROBLASTOMA. A SIOPEN STUDYPEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1058 - 1058Gaze, Mark N.Bomanji, Jamshed B.Brock, Penelope R.Flux, Glenn D.Lacerda, AnaMairs, Robert J.Saran, Frank H.Staudenherz, AntonUyttebroeck, AnneLadenstein, Ruth
- [39] Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialLANCET ONCOLOGY, 2024, 25 (07): : 922 - 932Corbacioglu, SelimLode, HolgerEllinger, SusanneZeman, FlorianSuttorp, MeinolfEscherich, GabrieleBochennek, KonradGruhn, BerndLang, PeterRohde, MariusDebatin, Klaus MichaelSteinbach, DanielBeilken, AndreasLadenstein, RuthSpachtholz, RainerHeiss, PeterHellwig, DirkTroeger, AnjaKoller, MichaelMenhart, KarinRiemenschneider, Markus J.Zoubaa, SaidaKietz, SilkeJakob, MarcusSommer, GunhildHeise, TilmanHundsdoerfer, PatrickKuehnle, IngridDilloo, DagmarSchoenberger, StefanSchwabe, Georgvon Luettichau, IreneGraf, NorbertSchlegel, Paul-GerhardtFruehwald, MichaelJorch, NorbertPaulussen, MichaelSchneider, Dominik T.Metzler, MarkusLeipold, AlfredNathrath, MichaelaImschweiler, ThomasChristiansen, HolgerSchmid, IreneCrazzolara, RomanNiktoreh, NaghmehCario, GunnarFaber, JoergDemmert, MartinBabor, Florian
- [40] The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective StudyPEDIATRIC BLOOD & CANCER, 2021, 68 : S213 - S214Wang, J.Zhen, Z.Zhu, S.Lian, Z.Lu, S.Sun, F.Huang, J.Zhang, Y.Sun, X.